Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

Interview with Proscia CEO David West

By Author Proscia | February 8, 2024

CEO David West recently joined David E. Williams on the “HealthBiz” podcast to share his entrepreneurial journey. He speaks to his  multidisciplinary approach, combining software, biology, and physics, which led to the creation of Proscia and our flagship, Concentriq. The discussion also focuses on digital pathology’s impact on the medical field.

Our website uses cookies. By using this site, you agree to its use of cookies.